Double-blind three-dose trial of oral alprenolol in angina pectoris.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood; D000328:Adult; D000368:Aged; D000605:Amino Alcohols / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood; D000787:Angina Pectoris / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004562:Electrocardiography; D005080:Exercise Test; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D005996:Nitroglycerin / Q000008:administration & dosage; D010919:Placebos; D013565:Sympatholytics / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D010919:Placebos; D013565:Sympatholytics; D005996:Nitroglycerin